These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

155 related items for PubMed ID: 29699057

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [Association of murine double minute 2 and P53 polymorphisms with breast cancer susceptibility].
    Wang ML, Xu YX, Qian J, Wang FH.
    Zhonghua Yu Fang Yi Xue Za Zhi; 2013 Feb; 47(2):124-8. PubMed ID: 23719102
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. The association of polymorphic markers Arg399Gln of XRCC1 gene, Arg72Pro of TP53 gene and T309G of MDM2 gene with breast cancer in Kyrgyz females.
    Isakova J, Talaibekova E, Aldasheva N, Vinnikov D, Aldashev A.
    BMC Cancer; 2017 Nov 13; 17(1):758. PubMed ID: 29132330
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. The T309G murine double minute 2 gene polymorphism is an independent prognostic factor for patients with renal cell carcinoma.
    de Martino M, Taus C, Wessely IS, Lucca I, Hofbauer SL, Haitel A, Shariat SF, Klatte T.
    DNA Cell Biol; 2015 Feb 13; 34(2):107-12. PubMed ID: 25415135
    [Abstract] [Full Text] [Related]

  • 7. The ID genotype of MDM2 40 bp insertion/deletion polymorphism was associated with lower risk of SLE.
    Salimi S, Rezaei M, Mohammadpour-Gharehbagh A, Sajadian M, Sandoughi M.
    Postgrad Med J; 2017 Dec 13; 93(1106):758-761. PubMed ID: 28676527
    [Abstract] [Full Text] [Related]

  • 8. Association between murine double minute 2 T309G polymorphism and risk of liver cancer.
    Tang T, Song X, Yang Z, Huang L, Wang W, Tan H.
    Tumour Biol; 2014 Nov 13; 35(11):11353-7. PubMed ID: 25119589
    [Abstract] [Full Text] [Related]

  • 9. Clinical significance of TP53 (R72P) and MDM2 (T309G) polymorphisms in breast cancer patients.
    Yadav P, Masroor M, Tanwer K, Mir R, Javid J, Ahmad I, Zuberi M, Kaza RC, Jain SK, Khurana N, Ray PC, Saxena A.
    Clin Transl Oncol; 2016 Jul 13; 18(7):728-34. PubMed ID: 26553387
    [Abstract] [Full Text] [Related]

  • 10. Murine double minute clone 2,309T/G and 285G/C promoter single nucleotide polymorphism as a risk factor for breast cancer: a Polish experience.
    Piotrowski P, Lianeri M, Rubis B, Knuła H, Rybczyńska M, Grodecka-Gazdecka S, Jagodziński PP.
    Int J Biol Markers; 2012 Jul 19; 27(2):e105-10. PubMed ID: 22467100
    [Abstract] [Full Text] [Related]

  • 11. Murine Double Minute 2 SNP T309G Polymorphism and Urinary Tract Cancer Risk: A Meta-Analysis.
    Ding H, Dai Y, Ning Z, Fan N, Wang Z, Li P, Zhang L, Tao Y, Wang H.
    Medicine (Baltimore); 2016 Mar 19; 95(12):e2941. PubMed ID: 27015167
    [Abstract] [Full Text] [Related]

  • 12. Association of MDM2 T309G (rs2279744) Polymorphism and Expression Changes With Risk of Prostate Cancer in the Slovak Population.
    Sivonova MK, Jurecekova J, Kaplan P, Hives M, Grendar M, Tomascova A, Dusenka R, Drobkova H, Evin D, Kliment J.
    Anticancer Res; 2020 Nov 19; 40(11):6257-6264. PubMed ID: 33109563
    [Abstract] [Full Text] [Related]

  • 13. Role of MDM2 T309G polymorphism in susceptibility and prognosis of nonsmall cell lung cancer: a meta-analysis.
    Kong Q, Li P, Tian Q, Ha MW.
    Genet Test Mol Biomarkers; 2014 May 19; 18(5):357-65. PubMed ID: 24673452
    [Abstract] [Full Text] [Related]

  • 14. Investigation of the association between the MDM2 T309G polymorphism and gastric cancer.
    Tas A, Atabey M, Caglayan G, Bostanci ME, Sahin Bolukbasi S, Topcu O, Silig Y.
    Biomed Rep; 2017 Nov 19; 7(5):469-473. PubMed ID: 29181159
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Relationship Between Murine Double Minute 2 (MDM2) T309G Polymorphism and Endometrial Cancer Risk: A Meta-Analysis.
    Xue Z, Zhu X, Teng Y.
    Med Sci Monit; 2016 Sep 08; 22():3186-90. PubMed ID: 27604213
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. MDM2 T309G polymorphism is associated with bladder cancer.
    Onat OE, Tez M, Ozçelik T, Törüner GA.
    Anticancer Res; 2006 Sep 08; 26(5A):3473-5. PubMed ID: 17094469
    [Abstract] [Full Text] [Related]

  • 20. Age-dependent association of MDM2 promoter polymorphisms and uterine leiomyoma in South-East Iran: A preliminary report.
    Salimi S, Hajizadeh A, Khodamian M, Pejman A, Fazeli K, Yaghmaei M.
    J Obstet Gynaecol Res; 2015 May 08; 41(5):729-34. PubMed ID: 25511444
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.